News
Tuesday, December 6, 2011
Mira Dx highlights breakthrough publication describing a marker for resistance to Platinum treatment in Ovarian Cancer
Wednesday, March 23, 2011
Importance of the KRAS-variant in early onset breast cancer shown in research study
Monday, March 7, 2011
Exploring the Clinical Value of KRAS Mutation Testing in Ovarian Cancer